Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Wellcare Announces Largest Medicare Advantage Expansion to Date
Wellcare, a wholly owned subsidiary of Centene Corporation, announced today its largest Medicare Advantage expansion […]
BHF Research Could Help Detect Early Signs of Heart Failure in Diabetic Patients
New research that BHF have funded in Leicester could help understand how heart failure can […]
Röchling Medical and Trendlines Innovation Labs Join Forces to Offer Top Innovation and Manufacturing Expertise to the Healthcare Industry
Röchling Medical, a division of the German-based Röchling Group and a leading manufacturer for the healthcare […]
Bayer to Invest Over €400 Million to Increase Access to Modern Contraception
Bayer today announced to invest over €400 million, reinforcing its commitment to providing 100 million […]
PEP-Therapy and Institut Curie Announce First Patients Dosed in Phase I Clinical Trial of PEP-010 for the Treatment of Advanced Solid Tumors
PEP-Therapy, a clinical-stage biotechnology company developing cell penetrating peptides as targeted therapies in oncology, and […]
Mogrify Strengthens Executive Leadership Team with the Appointment of Louise Modis as Chief Scientific Officer
Mogrify Limited (Mogrify®), a biopharmaceutical company pioneering the development of a new class of in vivo reprogramming therapies and transforming […]
CN Bio Expands Service Offering to Support Oncology Drug Discovery
CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single- and multi-organ microphysiological […]
seqWell Appoints New Commercial Team, Led by Chief Commercial Officer Steve Smith
seqWell, a global provider of next-generation sequencing (NGS) library technologies based on its proprietary plexWell™ multiplexing […]
NHS Announces Deal for Life Changing Sickle Cell Treatment
The first treatment for sickle cell disease in over 20 years will be rolled out […]
CrestOptics Introduces DeepSIM Super Resolution Confocal Microscope Module
CrestOptics S.p.A., a manufacturer of high-end microscopy solutions and advanced systems for fluorescence microscopy and […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more